T1D Fund

Investor type

VC

Founded

2015

AUM

$90 M

Location

United States

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Seed

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 03 February, 2026

Profile

Accelerating life-changing solutions to cure, prevent and treat type 1 diabetes (T1D) through catalytic equity investments. n 2015, JDRF identified a lack of investment in the T1D market. This was causing a gap between scientific advancements and commercial solutions made available to those who need them.



So JDRF created the T1D Fund to accelerate growth in the T1D investment market. As a separate entity, we can make compelling investments to stimulate private capital financing, whilst remaining efficient and nimble.

Industry

Biotechnology Healthcare Services Medical Devices Pharmaceuticals

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
QWihKle0nGEory7X QWihKle0nGEory7X
QWihKle0nGEory7X
avatar
QWihKle0nGEory7X QWihKle0nGEory7X
QWihKle0nGEory7X
avatar
QWihKle0nGEory7X QWihKle0nGEory7X
QWihKle0nGEory7X
avatar
QWihKle0nGEory7X QWihKle0nGEory7X
QWihKle0nGEory7X
avatar
QWihKle0nGEory7X QWihKle0nGEory7X
QWihKle0nGEory7X
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about T1D Fund

T1D Fund is located in United States.
T1D Fund was founded in 2015.
T1D Fund invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals.
T1D Fund invests in companies and startups in North America, Europe.
T1D Fund invests in companies and startups at Seed.
T1D Fund usually invests $1-5 m on average.
T1D Fund has around $90m assets under management.